A comparison of circulating TNF-α in obese and lean women with and without preeclampsia

Hypertension in Pregnancy

Volumn 27, Issue 1, 2008, Pages 39-48

  Founds, Sandra A ^a   Powers, Robert W ^b   Patrick, Thelma E ^a,b   Ren, Dianxu ^a   Harger, Gail F ^a   Markovic, Nina ^a   Roberts, James M ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

BMI; Obesity; Preeclampsia; TNF ; Tumor necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HUMAN; LEAN BODY WEIGHT; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NULLIPARA; OBESITY; PREECLAMPSIA; PREGNANCY OUTCOME; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; OBESITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; THINNESS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39749165639     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950701825838     Document Type: Article

References (29)

1. WHO. Beyond the numbers: Reviewing maternal deaths and complications to make pregnancy safer. Geneva, 2004.
2. NHBPEP. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183(1):S1-S22.
3. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997;37(3):240-249.
4. Roberts J. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16(1):5-15.
5. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999;20(3):114-118.
6. Moldawer LL. The tumor necrosis factor superfamily and its receptors. In: Paul WE, ed. Fundamental Immunology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2003.
7. Schipper EJ, Bolte AC, Schalkwijk CG, Van Geijn HP, Dekker GA. TNF-receptor levels in preeclampsia - results of a longitudinal study in high-risk women. J Matern Fetal Neonatal Med 2005;18(5):283-287.
8. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001;86(6):2505-2512.
9. Hayashi M, Ueda Y, Yamaguchi T, Sohma R, Shibazaki M, Ohkura T, et al. Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood. Am J Reprod Immunol 2005;53(3):113-119.
10. Hauner H. The new concept of adipose tissue function. Physiol Behav 2004;83(4):653-658.
11. Kobayashi K. Adipokines: therapeutic targets for metabolic syndrome. Curr Drug Targets 2005;6(4):525-529.
12. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92(3):347-355.
13. Evans RW, Powers RW, Ness RB, Cropcho LJ, Daftary AR, Harger GF, et al. Maternal and fetal amino acid concentrations and fetal outcomes during preeclampsia. Reproduction 2003;125(6):785-790.
14. Kaaja RJ, Poyhonen-Alho MK. Insulin resistance and sympathetic overactivity in women. J Hypertens 2006;24(1):131-141.
15. Bodnar LM, Ness RB, Harger GF, Roberts JM. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol. 2005;162(12):1198-1206.
16. Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001;98(5 Pt 1):757-762.
17. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis 2005;183(2):308-315.
18. Gonzalez F, Minium J, Rote NS, Kirwan JP. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90(9):5336-5342.
19. Gonzalez F, Minium J, Rote NS, Kirwan JP. Altered tumor necrosis factor alpha release from mononuclear cells of obese reproductive-age women during hyperglycemia. Metabolism 2006;55(2):271-276.
20. Bartha JL, Romero-Carmona R, Escobar-Llompart M, Comino-Delgado R. The relationships between leptin and inflammatory cytokines in women with preeclampsia. BJOG 2001;108(12):1272-1276.
21. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004;44(5):708-714.
22. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998;40(2):102-111.
23. Hamai Y, Fujii T, Yamashita T, Nishina H, Kozuma S, Mikami Y, et al. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997;38(2):89-93.
24. Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA, et al. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 1999;48(10):1332-1335.
25. Luppi P. How immune mechanisms are affected by pregnancy. Vaccine 2003;21(24):3352-3357.
26. Dong M, He J, Wang Z, Xie X, Wang H. Placental imbalance of Th1- and Th2-type cytokines in preeclampsia. Acta Obstet Gynecol Scand 2005;84(8):788-793.
27. Hunt JS, Chen HL, Miller L. Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod 1996;54(3):554-562.
28. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol. 1998 Nov;179 (5):1359-1375.
29. Visser W, Beckmann I, Knook MA, Wallenburg HC. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia. Acta Obstet Gynecol Scand. 2002 Aug;81(8):713-719.